Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.67 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.58 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.58 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.58 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.58 |
| ▸ | LDHA | P00338 | 1/20 | 0.58 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.58 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | SRC | P12931 | 1/20 | 0.58 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.58 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.58 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.58 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.58 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10865966 | 0.95 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL1920531 | 0.95 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL9231760 | 0.94 | EHMT1 (0.76) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL1637468 | 0.94 | EHMT1 (0.76) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL8671033 | 0.91 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL29936475 | 0.91 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL8671037 | 0.91 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 | |
| SCHEMBL8005428 | 0.88 | P2RY1 (0.60) | EHMT1ADORA1SMN1; SMN2P2RY1DNPH1 | |
| SCHEMBL10791195 | 0.88 | P2RY1 (0.69) | ADORA1SMN1; SMN2P2RY1DNPH1PRKAB2 | |
| SCHEMBL2534140 | 0.87 | EHMT1 (0.70) | EHMT1RXFP1ADORA1SMN1; SMN2P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070160554-A1 | Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same | COGNIS IP MANAGEMENT GMBH (DE) | 2007-07-12 | — | — | US | claimed |
| EP-1680435-A1 | ACYL RIBONUCLEOSIDES AND ACYL DEOXYRIBONUCLEOSIDES | Cognis IP Management GmbH (DE) | 2006-07-19 | — | — | EP | claimed |
| WO-2005049633-A1 | ACYL RIBONUCLEOSIDES AND ACYL DEOXYRIBONUCLEOSIDES | COGNIS IP MANAGEMENT GMBH (DE) | 2005-06-02 | — | — | WO | claimed |
| US-20070160554-A1 | Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same | COGNIS IP MANAGEMENT GMBH (DE) | 2007-07-12 | — | — | US | disclosed |
| EP-1680435-A1 | ACYL RIBONUCLEOSIDES AND ACYL DEOXYRIBONUCLEOSIDES | Cognis IP Management GmbH (DE) | 2006-07-19 | — | — | EP | disclosed |
| WO-2005049633-A1 | ACYL RIBONUCLEOSIDES AND ACYL DEOXYRIBONUCLEOSIDES | COGNIS IP MANAGEMENT GMBH (DE) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070160554-A1 | Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same | RNASEL, RNASEH1, DUT | EHMT1 1497/4885RXFP1 4394/4885ADORA1 415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.